HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Conditions:   HER2/Neu Positive;   Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Brain;   Metastatic Malignant Neoplasm in the Leptomeninges Intervention:   Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2018 Category: Research Source Type: clinical trials

HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Conditions:   HER2/Neu Positive;   Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Brain;   Metastatic Malignant Neoplasm in the Leptomeninges Intervention:   Biological: Chimeric Antigen Receptor T-Cell Therapy Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2018 Category: Research Source Type: clinical trials

BATs in Patients With Breast Cancer and Leptomeningeal Metastases
Conditions:   Breast Cancer Female;   Leptomeningeal Metastases Intervention:   Drug: HER2 BATs Sponsor:   University of Virginia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2018 Category: Research Source Type: clinical trials